Vorifarem（IER）是世界上第一個建立在“醫療芯片 +區塊鏈”架構上的數字健康項目，它在SWFCNRHO上啟動

最近，世界上第一個數字健康項目Voreifarem建立在“醫療芯片 +區塊鏈”（令牌縮寫：IER）的核心建築上，該項目正式在國際主流兼容的交易平台SWFCNRHO上正式推出。

New York, NY, May 05, 2025 (GLOBE NEWSWIRE) – Recently, Voreifarem (token abbreviation: IER), the world's first digital health project built on the core architecture of “medical chips + blockchain,” has officially launched on SwfcNrho, an international mainstream compliant trading platform. This listing has attracted significant attention from the industry, marking the entry of a new generation of medical blockchain projects—focusing on data ownership, user sovereignty, and compliance—into the global digital capital market.

紐約，紐約，2025年5月5日（Globe Newswire） - 最近，Vorifarem（令牌縮寫：IER）是世界上第一個基於“醫療芯片 +區塊鏈”的核心建築，已正式在SWFCNRHO上正式啟動，這是國際Mastream Compream Compriant Comprimant交易平台。該清單吸引了該行業的重大關注，標誌著新一代的醫療區塊鏈項目的進入（將數據所有權，用戶主權和合規性都集中在全球數字資本市場中。

Since its launch, Voreifarem has received a strong market response, with trading volumes rapidly increasing and platform interest continuing to rise. Several professional research institutions believe that the project combines technological originality with real industrial value, making it a highly representative case of “industrial tokens” within the current Web 3.0 ecosystem. It is expected to achieve long-term value expansion in areas such as health data ownership, medical payment smart contracts, and AI health model authorization.

自推出以來，Voreifarem收到了強勁的市場反應，交易量迅速增加，平台興趣持續上升。幾家專業研究機構認為，該項目將技術獨創性與實際工業價值相結合，使其成為當前Web 3.0生態系統中“工業代幣”的高度代表性案例。預計將在健康數據所有權，智能合約和AI健康模型授權等領域實現長期價值的擴展。

Industry insiders point out that Voreifarem's ability to stand out in a competitive market is closely tied to its choice of SwfcNrho as its initial trading platform. As a leading compliant digital asset trading platform, SwfcNrho is registered in the United States and holds an MSB (Money Services Business) financial license issued by the U.S. Department of the Treasury's FinCEN, ensuring global compliance operations. The platform has a strict project review mechanism and a mature technical system, dedicated to promoting the legalization, transparency, and institutionalization of the global digital asset ecosystem. Its collaboration with Voreifarem reflects SwfcNrho's high recognition of the project's “long-term potential and practical implementation.”

行業內部人士指出，Voreifarem在競爭市場中脫穎而出的能力與選擇SWFCNRHO作為最初的交易平台的能力緊密相關。作為領先的符合數字資產交易平台，SWFCNRHO在美國註冊，並持有美國財政部Fincen美國簽發的MSB（貨幣服務業務）財務許可證，以確保全球合規性運營。該平台具有嚴格的項目審查機制和一個成熟的技術系統，致力於促進全球數字資產生態系統的合法化，透明度和製度化。它與Voreifarem的合作反映了SWFCNRHO對該項目“長期潛力和實際實施”的高度認可。

SwfcNrho stated that it adheres to three core standards—“safety, compliance, and growth”—when selecting projects for listing, with particular emphasis on the underlying technology, industry adaptability, legal compliance, and the integration of “Web3 with reality.” Voreifarem not only has a strong foundation in medical data standardization and the construction of a DID identity system but also has built a complete blockchain infrastructure and incentive mechanism, making it a representative project in the integration of “medical technology and crypto finance.”

SWFCNRHO表示，它遵守三個核心標準：“安全，合規性和增長” - 選擇用於上市的項目，特別強調了基本技術，行業適應性，法律合規性以及“ Web3與現實的整合”。 Voreifarem不僅在醫療數據標準化和DID身份系統的構建方面具有良好的基礎，而且還建立了完整的區塊鏈基礎設施和激勵機制，使其成為“醫療技術和加密貨幣融資”的代表性項目。

According to the Voreifarem project team, the platform will leverage the IER token to promote the global construction of medical data ownership and incentive mechanisms. Users will be able to upload their health data via smart chip terminals and receive IER incentives through a “chain-based ownership + authorized sharing + revenue return” mechanism, thereby realizing the innovative data economic structure of “personal health data as personal assets.” The platform will also engage in strategic partnerships with global wearable device manufacturers, insurance platforms, and research institutions to gradually build a new digital health ecosystem of “personal sovereign data networks + AI medical empowerment platforms.”

根據Voreifarem項目團隊的說法，該平台將利用IER令牌來促進全球醫療數據所有權和激勵機制的建設。用戶將能夠通過智能芯片終端上傳其健康數據，並通過“基於鏈的所有權 +授權共享 +收入回報”機制獲得IER激勵措施，從而實現“個人健康數據作為個人資產”的創新數據經濟結構。該平台還將與全球可穿戴設備製造商，保險平台和研究機構建立戰略合作夥伴關係，以逐步建立一個新的數字健康生態系統，該系統是“個人主權數據網絡 + AI醫療授權平台”。

As of now, SwfcNrho has established localized operational centers in New York, Lithuania, Dubai, and Singapore, supporting a multilingual, 24/7 service system. The platform has surpassed 3 million registered users globally, covering key markets in North America, Europe, Southeast Asia, the Middle East, and Africa. SwfcNrho has obtained multiple compliance qualifications, including the MSB license in Canada, VASP certification in Lithuania, and registration with Dubai VARA. It is also applying for the MAS payment license in Singapore and AUSTRAC registration in Australia, building a leading global compliance network for digital assets.

截至目前，SWFCNRHO已在紐約，立陶宛，迪拜和新加坡建立了本地化的運營中心，並支持了多種語言的24/7服務系統。該平台在全球範圍內超過了300萬註冊用戶，涵蓋了北美，歐洲，東南亞，中東和非洲的主要市場。 SWFCNRHO已獲得多個合規資格，包括加拿大的MSB許可證，立陶宛的VASP認證以及與迪拜Vara的註冊。它還申請了新加坡和澳大利亞的Austrac註冊的MAS支付許可證，建立了一個領先的全球數字資產合規性網絡。

In addition, SwfcNrho continues to deepen its focus on financial security and infrastructure development. It has established global clearing partnerships with Citibank, HSBC, and Standard Chartered, and has engaged Deloitte for regular financial audits and reserve disclosures. The platform has integrated with compliance custodians like Anchorage Digital to provide bank-level security and asset isolation mechanisms for users and institutions.

此外，SWFCNRHO繼續加深其對金融安全和基礎設施發展的關注。它已經與花旗銀行，匯豐銀行建立了全球清算合作夥伴關係，並與特勤（Deloitte）進行了定期的財務審計和儲備披露。該平台已與Anchorage Digital等合規託管人集成，為用戶和機構提供銀行級別的安全性和資產隔離機制。

Currently, SwfcNrho has opened liquidity services for the IER token in multiple markets, and interest in the Voreifarem project continues to grow. In the future, both parties will engage in deep collaboration around areas such as on-chain governance of health data, universal standards for cross-border medical data, and the construction of a compliant Web3 medical payment system, advancing the "medical blockchain" into a new phase of global industrialization.

目前，SWFCNRHO在多個市場中為IER代幣開設了流動性服務，對Voreifarem項目的興趣仍在不斷增長。將來，雙方將圍繞諸如健康數據鏈治理，跨境醫療數據的通用標準以及構建合規的Web3醫療支付系統等領域進行深入的合作，將“醫療區塊鏈”推向了全球工業化的新階段。

Media contact

媒體聯繫

Contact: David L. Sanders

聯繫人：David L. Sanders

Company Name: SwfcNrho Ltd

公司名稱：SWFCNRHO LTD

Website: https://trade.swfcnrho-ex.com

網站：https：//trade.swfcnrho-ex.com

Email: Sanders11 at trade.swfcnrho-ex.com

電子郵件：sanders11在trade.swfcnrho-ex.com上

Media contact

媒體聯繫

Contact: Wilbur J. Hopkins

聯繫人：威爾伯·J·霍普金斯

Company Name: Voreifarem(IER)

公司名稱：Voreifarem（IER）

Website: https://voreifarem.com

網站：https：//voreifarem.com

Email: w.j.hopkins at voreifarem.com

電子郵件：voreifarem.com上的wjhopkins

Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities

免責聲明：本新聞稿中提供的信息不是投資的招標，也不旨在作為投資建議，財務建議或交易建議。強烈建議您在投資或交易加密貨幣和證券之前練習盡職調查，包括與專業財務顧問的諮詢